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INTRODUCTION
The middle cerebral artery (MCA) is the most commonly af-
fected artery in ischemic stroke.1-3 The MCA territory can be di-
vided into the superficial MCA territory and lenticulostriate ar-
tery (LSA) territory.4 Patients with superficial MCA territory 
infarction often develop devastating or fatal stroke.5,6
Patients with superficial MCA territory infarction may show 
concomitant involvement of the LSA territory. The LSA com-
monly originates from the proximal segment (M1) of the MCA 
trunk or the superior division of the MCA.7 Thus, the presence 
of concomitant LSA territory involvement in patients with su-
perficial MCA territory infarction provides information on the 
relevant artery of infarction, useful for the determination of 
stroke mechanisms.8,9 In addition, co-existing LSA involvement 
in patients with superficial MCA territory infarction may sug-
gest 1) occlusion of the MCA by larger thrombi, which may re-
sult in larger MCA territorial infarctions; 2) more frequent in-
volvement of the adjacent corticospinal tract, which can result 
in more severe or frequent motor weakness; and 3) a higher risk 
of brain herniation, because of deeply located sizable infarc-
tions. All these factors may affect patient outcomes. Further-
more, stroke mechanisms may differ in patients with superficial 
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MCA territory infarction, depending on the presence or ab-
sence of co-existing LSA territory infarction. 
In the present study, we compared the mechanisms thereof, 
severities of stroke, and long-term outcomes in patients with 
the superficial MCA territory infarction in relation to the pres-
ence or absence of LSA involvement.
MATERIRALS AND METHODS
Study population and group
This was a retrospective observational study using a prospec-
tively registered cohort data.10 The present study included pa-
tients admitted between January 2010 and December 2012 with 
first-ever infarction involving the unilateral MCA superficial 
territory within 7 days of symptom onset. Patients who had co-
exiting infarctions in other territories were excluded. The pa-
tients were evaluated using standardized protocols, including 
brain computed tomography (CT), magnetic resonance imag-
ing with diffusion-weighted imaging (DWI), and cerebral angi-
ographic studies, such as MR angiography, CT angiography, 
and digital subtraction angiography. Cardiac evaluation in-
cluded transesophageal echocardiography (TEE), transtho-
racic echocardiography (TTE), heart CT scan, and Holter or con-
tinuous electrocardiography monitoring during patient stay in 
the stroke unit. The patients were managed using standardized 
protocols of our stroke center based on given guidelines.11,12
We divided the patients with superficial MCA territory in-
farction into two groups according to the presence of concomi-
tant LSA territory infarction: the superficial MCA only (SM) 
group and the superficial MCA plus LSA (SM+L) group. The 
Institutional Review Board of Severance Hospital, Yonsei Uni-
versity Health System approved this study and waived the 
need for informed consent, owing to the retrospective and ob-
servational nature of the study.
Definition of risk factors 
Hypertension was defined as blood pressure recordings of 
systolic ≥140 mm Hg or diastolic ≥90 mm Hg on repeated mea-
surements during hospitalization or being on antihypertensive 
medication. Diabetes mellitus was diagnosed based on a fast-
ing plasma glucose level ≥7 mmol/L, a glycated hemoglobin 
value ≥6.5%, or when patients had been treated with oral hy-
poglycemic agents or insulin. Hypercholesterolemia was de-
fined as a fasting serum total cholesterol level ≥6.2 mmol/L, low-
density lipoprotein-cholesterol >4.1 mmol/L, or being treated 
with lipid lowering agents after a diagnosis of hypercholesterol-
emia. Patients were regarded as current smokers if they smoked 
within 1 year prior to admission. 
Mechanism of stroke
The mechanism of stroke was determined based on the Trial 
of Org 10172 in the Acute Stroke Treatment (TOAST) classifi-
cation.13 This study included patients with cardioembolism, 
large artery atherosclerosis, or stroke of undetermined etiology 
due to two or more identified causes or due to negative evalu-
ation. Patients with other determined etiologies were exclud-
ed from the study. Significant stenosis of the MCA or internal 
carotid artery (ICA) was defined as stenosis >50% or occlusion 
of the artery relevant to the infarction. We identified high-risk 
potential cardiac source of embolism (PCSE) based on the 
TOAST classification. The stroke subtype and the degree of ar-
terial stenosis were discussed during weekly stroke conferences 
and determined in consensus among stroke specialists. These 
data were registered in the prospective registry.
Infarction volume
The volume of infarction was measured on DWI in a semi-au-
tomatic manner using Xelis software (Infinitt, Seoul, Korea). 
An investigator (EHK) who was blinded to the clinical informa-
tion measured the infarction volumes for the superficial MCA 
territory and those for the LSA territory. The infarction volume 
of the superficial MCA territory was compared between the 
groups.
Stroke severity and long-term outcomes
Stroke severity was determined on the basis of National Insti-
tute of Health Stroke Scale (NIHSS) at admission. Significant 
brain swelling was defined as brain edema that required os-
motherapy or hemicraniectomy. Poor functional outcome was 
defined as a modified Rankin Scale (mRS) score >2 at 3 months 
after stroke onset. Long-term mortality and causes of death 
were identified by using death certificates from the Korean 
National Statistical Office, by reviewing medical records, and 
by conducting face-to-face or telephone interviews with a re-
search nurse or stroke specialist. Mortality data from the Kore-
an National Statistical Office are considered reliable, since they 
are collected on the basis of a unique 13-digit identification 
code assigned to subjects at birth and on the death certificate.14 
The cause of death was coded according to the International 
Classification of Disease (ICD), 10th revision. Stroke mortality 
was defined by the ICD code as I60–I69. Patients who were 
alive on August 31, 2014 were censored.
Statistical analyses
All statistical analyses were performed using SPSS software for 
Windows (version 20.0; SPSS Inc., Chicago, IL, USA). The Pear-
son χ2 test was used to compare the frequency of categorical 
variables. The independent t-test was used to compare contin-
uous variables. The variables achieving p-values less than 0.05 
in the univariate analyses were entered for multivariate analy-
ses using the logistic regression model to determine the factors 
associated with poor functional outcome. With regard to long-
term mortality, Kaplan-Meier analysis was used to estimate sur-
vival, and the log-rank test was used to compare rate estimates. 
We tested the proportional-hazards assumption by including 
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an interaction term between variables and natural log-trans-
formed follow-up time. Also, we checked log-minus-log sur-
vival plots. All variables met a proportional-hazards assump-
tion. Cox proportional hazard regression analysis was performed 
to calculate crude and adjusted hazard ratios (HR) with 95% 
confidence intervals (CI). All statistical analyses were two-
tailed, and p<0.05 was considered statistically significant.
RESULTS
Demographic and clinical characteristics of the 
patients
During the study period, 1754 consecutive patients were reg-
istered to the prospective cohort. At first, 885 patients were ex-
cluded because they did not have any infarction in the superfi-
cial MCA territory. After excluding 180 patients with co-existing 
infarctions in other territories or bilateral superficial MCA ter-
ritories, 689 patients had unilateral infarction involving the 
superficial MCA territory. Of the 689 patients, we excluded 
291 patients who received thrombolytic treatment, had a his-
tory of previous cerebral infarction, had other determined etiol-
ogy based on the TOAST classification, or did not undergo DWI 
or cerebral angiography. Finally, 398 patients were included 
in this study (Supplementary Fig. 1, only online). 
Of the 398 patients with superficial MCA territory infarc-
tion, the mean age was 66.9±11.7 years and 273 (68.6%) were 
men. Of the 398 patients, 369 (92.7%) underwent at least one 
cardiac evaluation (heart CT in 278, TEE in 245, and TTE in 
197), and 295 patients (74.1%) were evaluated using continuous 
electrocardiography monitoring for at least 24 hours. Eighty-
four patients (21.1%) had concomitant lesions in the LSA ter-
ritory (SM+L group). The SM+L group showed higher levels of 
white blood cells than the SM group. The other demographic 
characteristics were not different between the groups (Table 1).
Table 1. Comparison of Baseline Characteristics 
SM (n=314) SM+L (n=84) p value
Age, yr 66.5±11.4 68.6±13.0 0.148
Sex, men 219 (69.7) 54 (64.3) 0.338
Hypertension 222 (70.7) 60 (71.4) 0.896
Diabetes 136 (43.3) 34 (40.5) 0.641
Hypercholesterolemia 45 (14.3) 8 (9.5) 0.249
Current smoking 82 (26.1) 17 (20.2) 0.268
Coronary heart disease 74 (23.6) 19 (22.6) 0.855
Previous medication
Antiplatelet 116 (36.9) 25 (29.8) 0.222
Anticoagulant 23 (7.3) 3 (3.6) 0.216
Statin 68 (21.7) 17 (20.2) 0.778
Antihypertensive 138 (43.9) 43 (51.2) 0.236
Diabetes medication 25 (8.0) 4 (4.8) 0.316
Initial NIHSS 4.02±4.97 10.83±7.11 <0.001
Significant brain swelling 10 (3.2) 13 (15.5) <0.001
Laboratory results
Hemoglobin, g/dL 13.9±2.1 14.2±1.8 0.157
Hematocrit, % 40.7±5.8 41.9±4.9 0.091
White blood cells, K/mm3 8.0±2.8 9.1±3.2 0.005
Platelet, K/mm3 245.5±84.2 247.9±73.6 0.818
Prothrombin time, INR 1.0±0.3 1.0±0.2 0.848
ESR, mm/H 25.8±23.5 25.9±21.7 0.976
hsCRP, mg/dL 11.3±29.5 22.5±50.0 0.057
Total cholesterol, mmol/L 4.7±1.1 4.6±1.1 0.453
LDL cholesterol, mmol/L 2.7±0.9 2.8±0.9 0.181
HDL cholesterol, mmol/L 1.1±0.3 1.1±0.3 0.928
Fasting sugar, mmol/L 6.6±2.4 6.6±2.1 0.907
Glycated hemoglobin, % 6.6±1.4 6.6±1.3 0.685
SM, superficial middle cerebral artery only; SM+L, superficial middle cerebral artery plus lenticulostriate artery; NIHSS, National Institutes of Health Stroke 
Scale; INR, international normalized ratio; ESR, erythrocyte sedimentation rate; hsCRP, high sensitivity C-reactive protein; LDL, low-density lipoprotein; HDL, 
high-density lipoprotein.
Data are number (%), mean±standard deviation.
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Mechanism of infarction
Stroke subtypes were different between the groups. Large ar-
tery atherosclerosis and two or more causes were more com-
mon in the SM+L group. Negative evaluation was more frequent 
in the SM group (20.1%) than in the SM+L group (4.8%). Com-
pared with the SM group, the SM+L group more commonly had 
significant stenosis of the MCA or ICA relevant to an infarc-
tion and high-risk PCSE (Table 2).
Table 2. Subtype and Stroke Mechanisms
SM (n=314) SM+L (n=84) p value
Stroke subtype 0.003
Large artery atherosclerosis* 76 (24.2) 31 (36.9)
Cardioembolism 109 (34.7) 27 (32.1)
Two or more causes* 66 (21.0) 22 (26.2)
Negative evaluation 63 (20.1) 4 (4.8)
Stroke mechanism
Significant MCA stenosis 43 (13.7) 33 (39.3) <0.001
Significant ICA stenosis 45 (14.3) 28 (33.3) <0.001
High-risk PCSE 84 (26.8) 35 (41.7) 0.008
SM, superficial MCA only; SM+L, superficial MCA plus lenticulostriate artery; MCA, middle cerebral artery; ICA, internal carotid artery, PCSE, potential cardiac 
source of embolism.
Values are numbers (%).
*p<0.005; comparison with negative evaluation using Bonferroni post-hoc analysis.
Fig. 1. Comparison of mean NIHSS scores for each item between the groups. Scores for all NIHSS items except that for limb ataxia are significantly 
higher in the SM+L group. NIHSS, National Institute of Health Stroke Scale; SM, superficial middle cerebral artery only; SM+L, superficial middle ce-
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Initial stroke severity and infarct volumes
Initial neurologic deficits were more severe in the SM+L group 
than in the SM group (mean NIHSS, 10.83±7.11 vs. 4.02±4.97, 
p<0.001) (Table 1). We compared the scores of each NIHSS 
item between the groups to determine whether the higher NI-
HSS score in the SM+L group was due to symptoms related 
with LSA lesions, such as weakness, dysarthria, and sensory 
changes. In doing so, scores for all NIHSS items, except those 
for ataxia, were significantly higher in the SM+L group (Fig. 1). 
The infarct volume of the superficial MCA territory was larger 
in the SM+L group than in the SM group (40.8±62.6 cm3 vs. 
10.8±21.8 cm3, p<0.001) (Supplementary Fig. 2, only online). 
Significant brain swelling was also more frequent in the SM+L 
group (15.5% vs. 3.2%, p<0.001) (Table 1).
Long-term outcomes
Poor functional outcome (mRS>2) at 3 months was more com-
mon in the SM+L group than in the SM group (64.3% vs. 15.9%, 
p<0.001) (Fig. 2). Univariate analysis showed that the patients 
with poor functional outcome were less commonly men, were 
Fig. 2. Modified Rankin Scale at 3 months of symptom onset. Numbers are percentages (%). SM, superficial middle cerebral artery only; SM+L, super-
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Table 3. Univariate Analysis of Factors Associated with a Poor Outcome at 3 Months
Patient with favorable outcome (n=294) Patient with poor outcome (n=104) p value
Age, yr 65.1±11.6 72.0±10.6 <0.001
Sex, men 210 (71.4) 63 (60.6) 0.040
LSA involvement 30 (10.2) 54 (51.9) <0.001
Hypertension 204 (69.4) 78 (75.0) 0.279
Diabetes 124 (42.3) 46 (44.2) 0.716
Hypercholesterolemia 41 (13.9) 12 (11.5) 0.535
Current smoking 83 (28.2) 16 (15.4) 0.009
Coronary heart disease 71 (24.1) 22 (21.2) 0.535
Initial NIHSS 3.11±3.73 12.10±6.76 <0.001
Significant brain swelling 3 (1.0) 20 (19.2) <0.001
Significant MCA stenosis 37 (12.6) 39 (37.5) <0.001
Significant ICA stenosis 40 (13.6) 33 (31.7) <0.001
High-risk PCSE 71 (24.1) 48 (46.2) <0.001
Laboratory results
Hemoglobin, g/dL 13.9±2.0 13.8±2.2 0.315
White blood cells, K/mm3 7.8±2.6 9.3±3.4 <0.001
Platelet, K/mm3 245.2±79.1 248.2±90.2 0.752
Prothrombin time, INR 1.0±0.3 1.0±0.2 0.827
ESR, mm/H 23.4±21.5 32.2±26.0 0.002
hsCRP, mg/dL 8.5±22.5 28.4±54.8 0.001
Total cholesterol, mmol/L 4.7±1.1 4.5±1.1 0.045
LDL cholesterol, mmol/L 2.7±0.8 2.8±1.0 0.575
HDL cholesterol, mmol/L 1.1±0.3 1.1±0.3 0.174
Fasting sugar, mmol/L 6.4±2.4 6.9±2.4 0.121
Glycated hemoglobin, % 6.6±1.4 6.6±1.3 0.971
LSA, lenticulostriate artery; NIHSS, National Institutes of Health Stroke Scale; MCA, middle cerebra artery; ICA, internal carotid artery; PCSE, potential cardiac 
source of embolism; INR, international normalized ratio; ESR, erythrocyte sedimentation rate; hsCRP, high sensitivity C-reactive protein; LDL, low-density lipopro-
tein; HDL, high-density lipoprotein.
Data are number (%), mean±standard deviation.
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more commonly older age, and had more commonly LSA in-
volvement, current smoking history, higher initial NIHSS score, 
significant brain swelling, significant MCA stenosis, significant 
ICA stenosis, high-risk PCSE, and higher white blood cell count, 
ESR, hsCRP and total cholesterol levels (Table 3). Multivariate 
logistic regression analysis showed that LSA involvement was 
an independent predictor of poor functional outcome (ad-
justed odds ratio 3.686, 95% CI 1.693–8.027, p= 0.001), along 
with age, initial NIHSS, significant stenosis of the MCA or ICA 
relevant to an infarction, and the infarct volume of the super-
ficial MCA territory (Table 4). 
During a follow-up of mean 26±15 months, 67 patients (16.8%) 
died. Eighteen patients (4.5%) died of stroke. The SM+L group 
showed significantly higher all-cause mortality (HR, 2.246; 95% 
CI, 1.339–3.768) (Fig. 3A) and stroke mortality (HR, 9.193; 95% 
CI, 3.442–24.556) (Fig. 3B) than the SM group. Multivariate Cox 
regression analysis, after adjusting factors that were significant 
on univariate Cox regression analysis (Supplementary Table 1, 
only online), showed that LSA involvement was independent-
ly associated with long-term stroke mortality along with age, 
higher initial NIHSS, significant brain swelling, and significant 
stenosis of the MCA trunk (Table 5). Meanwhile, however, mul-
tivariate Cox regression analysis (Supplementary Table 2, only 
online), revealed that LSA involvement was not independent-
ly associated with all-cause mortality. 
DISCUSSION
In the present study, we investigated whether initial stroke se-
verity, stroke mechanism, and long-term outcomes differed 
among patients with superficial MCA territory infarction ac-
cording to the presence or absence of co-existing LSA territory 
infarction. We found that initial neurologic deficits were more 
severe in patients with SM+L group than in those with SM alone. 
LSA involvement can cause weakness, sensory changes, or 
dysarthria,15,16 and these symptoms might have contributed to 
the severe neurologic deficits in the SM+L group. However, when 
baseline NIHSS scores for each item were compared between 
the groups, all of the items except for ataxia showed higher 
Table 4. Multivariate Analysis of Factors Associated with a Poor Outcome at 3 Months
Adjusted odds ratio 95% CI p value
Age, per increment of 10 2.048 1.422–2.952 <0.001
Sex, men 0.700 0.335–1.463 0.343
Initial NIHSS score 1.203 1.129–1.292 <0.001
Superficial MCA territorial infarction volume, per increment of 1 cm3 1.016 1.002–1.032 0.031
Significant brain swelling 4.903 0.743–32.362 0.099
Significant MCA stenosis 2.868 1.209–6.806 0.017
Significant ICA stenosis 3.707 1.617–8.498 0.002
High-risk PCSE 1.514 0.702–3.264 0.290
White blood cells, per increment of 1000 1.105 0.981–1.244 0.101
Involvement of LSA territory 3.686 1.693–8.027 0.001
NIHSS, National Institute of Health Stroke Scale; MCA, middle cerebral artery; ICA, internal carotid artery; PCSE, potential cardiac source of embolism; LSA, len-
ticulostriate artery; CI, confidence interval.
Fig. 3. Kaplan-Meier curve for all-cause mortality (A) and stroke mortality (B). SM, superficial middle cerebral artery only; SM+L, superficial middle 
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scores in the SM+L group. These results suggest that the severe 
neurologic deficits in SM+L patients may be attributed to the 
wider hemispheric dysfunction, not simply the consequence 
of the additional LSA territory infarction. Consistent with this 
hypothesis, the infarction volume of the MCA superficial terri-
tory excluding that in the LSA territory was much greater in 
SM+L patients than in SM patients. 
The initially severe stroke in the SM+L group could be, in part, 
ascribed to differences in the stroke mechanisms between SM 
and SM+L. In the present study, the SM+L group more fre-
quently had significant stenosis or occlusion in the MCA or 
ICA and high-risk PCSE than the SM group. The larger infarc-
tion volume in the SM+L group might be associated with those 
etiologies. The possible mechanisms of superficial MCA terri-
tory infarction are embolism from the heart, artery-to-artery 
embolism from the proximal arterial trees, such as the aorta, 
carotid artery and MCA, and in-situ thrombosis of the MCA,17,18 
To produce the concomitant LSA lesion, thrombi from the 
heart or proximal arteries should be large enough to occlude 
the MCA trunk or multiple to involve both the superficial MCA 
and LSA territories.19,20 In patients with significant stenosis of 
the MCA, thromboemboli from the heart or proximal arteries 
might have been more easily trapped at the MCA trunk to 
completely occlude the MCA.21 In addition, cardioembolism is 
known to produce larger infarction and more severe stroke.22,23 
Finally, the local MCA trunk atheroma could also be the source 
of the emboli to both the LSA and the superficial MCA branches.
In this study, the presence of LSA territory infarction was an 
independent predictor of poor long-term outcomes and in-
creased risk of mortality, even after adjustment for the initial 
NIHSS score and infarction volume. Functional outcome mea-
sured by mRS, largely depends on the degree of motor weak-
ness.24 Motor tracts, which pass as compact bundles through 
the internal capsule,25 could be more frequently damaged in 
the SM+L group, and this might have caused more severe mo-
tor weakness and impeded functional recovery. In patients with 
large superficial territory infarction, additionally sizable infarc-
tions in the subcortex due to LSA involvement might increase 
the risk of compressing deep brain structures and brain herni-
ation. In a previous study, patients who had both large artery 
atherosclerosis and cardioembolism showed very high long-
term mortality, while those without showed very low long-term 
mortality.26 Consistent with the previous findings, the SM+L 
group more frequently had two or more causes (large artery 
atherosclerosis and cardioembolism), while the SM group 
more frequently had undetermined etiology due to negative 
evaluation.
This study has limitations. First, this study is not free from 
selection bias because this was a retrospective study, although 
the cohort data were prospectively and consecutively collect-
ed. Second, patients who received reperfusion therapy were 
excluded from this study. Consequently, some patients with 
hyperacute MCA infarction were not included in this analysis. 
Third, the mortality rate of this study is relatively low, com-
pared to the previous studies.27,28 We excluded patients with 
co-existing infarctions in other territories or those with recana-
lization therapy. These patients might have initially more se-
vere stroke that may be associated with stroke mortality. In addi-
tion, cause of death was determined based on medical records or 
death certificates in some patients. Thus, stroke mortality might 
not be accurately reflected in some patients. Finally, although 
the infarction volume in the superficial MCA territory can be 
influenced by the presence and degree of collateral circula-
tions,20,29 they could not be determined because the angiograph-
ic studies were not standardized.
In conclusion, among patients with superficial MCA territo-
ry infarction, the presence of co-existing LSA territory infarc-
tion was associated with initially severe stroke and larger in-
farct volume in the MCA superficial territory. LSA involvement 
was almost the most powerful predictor of poor functional out-
come and stroke mortality. Therefore, greater concern should 
be given when treating patients with MCA superficial territory 
infarction and a co-existing LSA lesion.
Table 5. Cox Regression Model of Stroke Mortality in Multivariate Analysis
Model 1 Model 2
HR (95% CI) p value HR (95% CI) p value
Age, yr, per increment of 10 2.114 (1.300–3.537) 0.003 1.983 (1.193–3.297) 0.008
Sex, men 3.231 (0.946–11.042) 0.061 2.009 (0.632–6.383) 0.237
Involvement of LSA territory 3.652 (1.071–12.454) 0.038 4.230 (1.394–12.838) 0.011
Erythrocyte sedimentation rate 1.008 (0.998–1.028) 0.431
Initial NIHSS score 1.117 (1.020–1.222) 0.016
Superficial MCA territorial infarction volume, per increment of 1 cm3 1.000 (0.990–1.011) 0.958
Significant brain swelling 3.302 (1.094–9.961) 0.034
Significant MCA stenosis 3.176 (1.069–9.441) 0.038
Significant ICA stenosis 3.108 (0.992–9.742) 0.052
LSA, lenticulostriate artery; NIHSS, National Institute of Health Stroke Scale; MCA, middle cerebral artery; ICA, internal carotid artery.
Model 1 includes age, sex, erythrocyte sedimentation rate, initial NIHSS, superficial territorial infarction volume and involvement of LSA and model 2 includes 
age, sex, significant brain swelling, significant MCA stenosis, significant ICA stenosis and involvement of LSA.
https://doi.org/10.3349/ymj.2017.58.1.123130
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